Thames Ventures VCT 2 plc (TV2H) Ord GBP0.001 Healthcare
Sell:46.00p
Buy:49.00p
0
Change:
No change
No change
Market closed |
Prices as at close on 14 May 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
- Add to watchlist
- This stock can be held in a
Sell:46.00p
Buy:49.00p
Change:
No change
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Market closed |
Prices as at close on 14 May 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
Sell:46.00p
Buy:49.00p
Change:
No change
No change
Market closed |
Prices as at close on 14 May 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Objective
It is intended that at least 70% funds of each share pools are invested in VCT Qualifying Investments within 3 years of the close of the relevant share offer. The remainder of the funds will be held in non qualifying investments. New VCT Qualifying Investments will normally comprise investments sector in businesses that are less than 7 years old and require funding to support the growth of the business. The pool focuses on healthcare sector.
| Security | Weight |
|---|---|
| Arecor Therapeutics plc ORD GBP0.01 | 17.89% |
| ADAPTIX LIMITED | 11.39% |
| OPEN BIONICS LIMITED | 10.08% |
| Fvrvs Limited (T/A Fundamental Vr) | 9.64% |
| Ge Nin Code Plc | 6.69% |
| Congenica Limited | 5.35% |
| Cambridge Respiratory Innovations Limited | 4.95% |
| Closed Loop Medicine Limited | 4.02% |
| Dia Imaging Analysis Limited | 3.51% |
| The Electrospinning Company Limited | 3.36% |
Top 10 sectors currently unavailable.
| Country | Weight |
|---|---|
| United Kingdom | 20.07% |
Fee Structure
The Manager receives an annual fee of 2.5% of the NAV. The management team is entitled to receive a performance fee.
Dividend Policy
The Board has a stated objective for the Healthcare Share pool of paying an annual taxâfree dividend from the fourth year onwards of at least 4% on the NAV of the pool.
ASSET SPLIT
Trust Manager
Not Disclosed
Manager Bio
Not currently available for this investment trust.
Board Of Directors
Aubrey BrocklebankChairman, Chris Allner, Andrew Mackintosh, Steven Clarke
Data policy - All information should be used for indicative purposes only. You should
independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete,
and accepts no responsibility for how it may be used.
Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.